Company / Cash per Share
Aligos Therapeutics, Inc. Cash per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.23
FY2025
5-year range
$0.23 / $12.32
FY2021-FY2025
Trend
-98.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $3.16 to $0.23 over the past 2 years.
Based on SEC 10-K filings.
0.23 in FY2025 with a 5-year CAGR of -66.7%.
Declined from $3.16 to $0.23 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -50.6%
- 5-Year CAGR
- -66.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share decreased 98.1% year-over-year.
- Peak cash per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.23 | -98.1% |
| FY2024 | $12.32 | +289.6% |
| FY2023 | $3.16 | +65.9% |
| FY2022 | $1.91 | -61.1% |
| FY2021 | $4.90 | -91.3% |
| FY2020 | $56.11 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026